These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34929570)

  • 1. Process monitoring of polysaccharide deketalization for vaccine bioconjugation development using in situ analytical methodology.
    Lomont JP; Ralbovsky NM; Guza C; Saha-Shah A; Burzynski J; Konietzko J; Wang SC; McHugh PM; Mangion I; Smith JP
    J Pharm Biomed Anal; 2022 Feb; 209():114533. PubMed ID: 34929570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-clinical immunological comparison of a Next-Generation 24-valent pneumococcal conjugate vaccine (VAX-24) using site-specific carrier protein conjugation to the current standard of care (PCV13 and PPV23).
    Fairman J; Agarwal P; Barbanel S; Behrens C; Berges A; Burky J; Davey P; Fernsten P; Grainger C; Guo S; Iki S; Iverson M; Kane M; Kapoor N; Marcq O; Migone TS; Sauer P; Wassil J
    Vaccine; 2021 May; 39(23):3197-3206. PubMed ID: 33965258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-time
    Saha-Shah A; Smith JP; Konietzko J; Costell E; McHugh PM; Lo-Mont JP; Ralbovsky NM; Obando L; Wang SC; Appiah-Amponsah E; Mangion I
    Bioanalysis; 2023 May; 15(9):493-501. PubMed ID: 37141441
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of pneumococcal polysaccharide conjugate vaccine with long spacer arm.
    Wu D; Ji S; Hu T
    Vaccine; 2013 Nov; 31(48):5623-6. PubMed ID: 24120485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of individual conjugate dose on immunogenicity of type 6B pneumococcal polysaccharide-N. meningitidis outer membrane protein complex conjugate vaccines in infant rhesus monkeys.
    McNeely TB; Liu X; Bringman T; Donnelly JJ
    Vaccine; 2000 Jun; 18(25):2808-16. PubMed ID: 10812223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of previous vaccination with pneumococcal conjugate vaccine on pneumococcal polysaccharide vaccine antibody responses.
    Schaballie H; Wuyts G; Dillaerts D; Frans G; Moens L; Proesmans M; Vermeulen F; De Boeck K; Meyts I; Bossuyt X
    Clin Exp Immunol; 2016 Aug; 185(2):180-9. PubMed ID: 26939935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of Streptococcus pneumoniae Colonization and Dissemination by a Nonopsonic Capsular Polysaccharide Antibody.
    Doyle CR; Pirofski LA
    mBio; 2016 Feb; 7(1):e02260-15. PubMed ID: 26838726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in Homing Potentials of Streptococcus pneumoniae-Specific Plasmablasts in Pneumococcal Pneumonia and After Pneumococcal Polysaccharide and Pneumococcal Conjugate Vaccinations.
    Palkola NV; Pakkanen SH; Kantele JM; Pakarinen L; Puohiniemi R; Kantele A
    J Infect Dis; 2015 Oct; 212(8):1279-87. PubMed ID: 25838267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older.
    Jackson LA; Gurtman A; van Cleeff M; Frenck RW; Treanor J; Jansen KU; Scott DA; Emini EA; Gruber WC; Schmoele-Thoma B
    Vaccine; 2013 Aug; 31(35):3594-602. PubMed ID: 23688525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A New Pneumococcal Capsule Type, 10D, is the 100th Serotype and Has a Large
    Ganaie F; Saad JS; McGee L; van Tonder AJ; Bentley SD; Lo SW; Gladstone RA; Turner P; Keenan JD; Breiman RF; Nahm MH
    mBio; 2020 May; 11(3):. PubMed ID: 32430472
    [No Abstract]   [Full Text] [Related]  

  • 11. Expanding the Scope of Ugi Multicomponent Bioconjugation to Produce Pneumococcal Multivalent Glycoconjugates as Vaccine Candidates.
    Humpierre AR; Zanuy A; Saenz M; Garrido R; Vasco AV; Pérez-Nicado R; Soroa-Milán Y; Santana-Mederos D; Westermann B; Vérez-Bencomo V; Méndez Y; García-Rivera D; Rivera DG
    Bioconjug Chem; 2020 Sep; 31(9):2231-2240. PubMed ID: 32809806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants.
    Zangwill KM; Greenberg DP; Chiu CY; Mendelman P; Wong VK; Chang SJ; Partridge S; Ward JI
    Vaccine; 2003 May; 21(17-18):1894-900. PubMed ID: 12706674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with pneumococcal polysaccharide conjugate vaccine (conjugated to CRM197 carrier protein) in children and adults.
    Durando P; Faust SN; Fletcher M; Krizova P; Torres A; Welte T
    Clin Microbiol Infect; 2013 Oct; 19 Suppl 1():1-9. PubMed ID: 24083785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional anti-polysaccharide IgG titres induced by unadjuvanted pneumococcal-conjugate vaccine when delivered by microprojection-based skin patch.
    Pearson FE; Muller DA; Roalfe L; Zancolli M; Goldblatt D; Kendall MA
    Vaccine; 2015 Nov; 33(48):6675-83. PubMed ID: 26518398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of multiple regimens of pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine and pneumococcal polysaccharide vaccine in toddlers.
    Blum MD; Dagan R; Mendelman PM; Pinsk V; Giordani M; Li S; Bohidar N; McNeely TB
    Vaccine; 2000 May; 18(22):2359-67. PubMed ID: 10738092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
    Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y
    Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: review of evidence on indirect effects.
    Davis SM; Deloria-Knoll M; Kassa HT; O'Brien KL
    Vaccine; 2013 Dec; 32(1):133-45. PubMed ID: 23684824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines.
    Anttila M; Eskola J; Ahman H; Käyhty H
    J Infect Dis; 1998 Jun; 177(6):1614-21. PubMed ID: 9607841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety, tolerability, and immunogenicity of 15-valent pneumococcal conjugate vaccine in healthy adults.
    McFetridge R; Meulen AS; Folkerth SD; Hoekstra JA; Dallas M; Hoover PA; Marchese RD; Zacholski DM; Watson WJ; Stek JE; Hartzel JS; Musey LK
    Vaccine; 2015 Jun; 33(24):2793-9. PubMed ID: 25913828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conjugation of polysaccharide 6B from Streptococcus pneumoniae with pneumococcal surface protein A: PspA conformation and its effect on the immune response.
    Perciani CT; Barazzone GC; Goulart C; Carvalho E; Cabrera-Crespo J; Gonçalves VM; Leite LC; Tanizaki MM
    Clin Vaccine Immunol; 2013 Jun; 20(6):858-66. PubMed ID: 23554468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.